FYI - For Your Innovation

Rivian has resurrected Steve Job's "One More Thing..." This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous discuss the launch of not one, not two, but three new Rivian's as well as Starlink's new direct-to-device service.If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.Key Points From This Episode:Rivian Launches Three New VehiclesStarlink Has a New Direct-to-device ServiceFor more updates on Public.com:Website: https://public.com/YouTube: @publicinvestTwitter: https://twitter.com/public

Former NBA stars Andre Iguodala and Evan Turner share their journey from the basketball court to venture capital, emphasizing financial literacy, mentorship, and networking. They discuss overcoming challenges, embracing innovation, and building something great, showcasing the intersection of sports, innovation, and entrepreneurship.

The podcast discusses the AI race and current competitors, highlighting the potential for worker productivity improvement. They explore Klarna's AI assistant, Google's challenges in innovating, and the impact of AI on customer service. The episode also covers the use of AI chatbots in navigating cellular plans and the innovations and challenges in the AI landscape.

Bitcoin Brainstorm features industry leaders discussing bitcoin's uniqueness, mining pools, innovation pace, energy consumption, and convergence with money. They explore decentralization, renewable energy, community benefits, regulatory challenges, education initiatives, and community building through Bitcoin meetups.

CEO Ben Lamm discusses reviving extinct species with AI and genetic editing, focusing on bringing back the woolly mammoth. The podcast explores the fusion of technology and conservation, regulatory challenges, and the impact on genetic research. Lamm's journey from tech to biotech highlights the innovative approach to de-extinction and conservation efforts.

Walmart's plans to acquire Vizio and the European Central Bank's criticism of Bitcoin are discussed in this episode. The team explores the implications of Walmart entering the connected TV industry and debunk common misconceptions about Bitcoin's investment value and privacy concerns.

The podcast discusses SoFi's evolution from student loans to a comprehensive financial platform, the role of AI in enhancing customer service, the importance of trust in finance, democratization in financial services, and SoFi's innovative approach to integrating investment, loan, and savings products on a single platform.

RewindAI CEO Dan Siroker discusses overcoming human mind limitations and redefining AI assistants. Topics include voice interaction in AI, privacy in wearables, revolutionizing note-taking, and building trust through transparency.

In this podcast, Cathie Wood and Brett Winton discuss technological convergence, artificial intelligence, and the disruptive potential of technological innovation. They also touch on topics such as the impact of AI on economic growth, negative trends in banking, and the relationship between metals to gold ratio and treasury bond yield.

Sam Korus, Nick Grous, Brett Winton, and Ali Urman discuss Sam Altman's plan to raise $7 trillion for an AI chip. They explore the exponential growth of AI, the impact of quantum, recreation, and AlphaGo, and the high drug prices in the US compared to other countries. They also analyze the viability of Mark Cuban's generics company and discuss the impact of drug pricing on affordability and access to care.